Dinoprost tromethamine salt| CAS 38562-01-5

Cas No.:	38562-01-5
Chemical Name:	Dinoprost tromethamine salt
Synonyms:	Prostaglandin F2a tris salt;Prostaglandin F2-alpha tromethamine salt;(5Z,9a,11a,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dienoic acid tris salt;Dinoprost;Dinorprost tromethamine;PGF2α (Prostaglandin F2α);Prostaglandin F2α;Prostaglandin F2α (tromethamine salt);Prostaglandin F2α Tr;Prostaglandin F2α tris salt;Prostaglandin F2α Tromethamine Salt;Dinoprost tromethamine;Dinoprost trometamol;PGF2α THAM;Prostaglandin F2a tromethamine salt;Prostaglandin F2α THAM;(5Z,9α,11α,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dienoic acid tris salt;PGF2α−Tris;Dinolytic;Zinoprost;PGF2-alpha tham;Prostalmon F;Prostin F2 alpha;Lutalyse;PGF2alpha THAM;Pronalgon F;Prostaglandin F2alpha tham;Panacelan F tromethamine salt;Prostaglandin F2-alpha THAM;Prostaglandin F2a tromethamine;Dinoprost, trometamol salt;THAM PGF2-alpha;Ensaprost;Lutalyse (Veterinary);PGF2-alpha tris salt;PGF2-alpha tromethamine;Enzaprost F compd. with trisamine;PGF2-alpha tromethamine salt;Protaglandin F2-alpha-tham salt;Prostaglandi;CID 126963607;Dinoprost tromethamine salt;Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9α,11α,13E,15S)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1);Prostaglandin F2α THAM salt;Prostaglandin F2α tris(hydroxymethyl)aminomethane;Prostaglandin F2α tris(hydroxymethyl)aminomethane salt;Prostaglandin F2α tromethamine;Prostaglandin F2α tromethamine salt;Prostaglandin F2α-tham;THAM PGF2α
SMILES:	O([H])[C@@]1([H])C([H])([H])[C@]([H])([C@]([H])(C([H])=C([H])[C@]([H])(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O[H])[C@]1([H])C([H])([H])C([H])=C([H])C([H])([H])C([H])([H])C([H])([H])C(=O)O[H])O[H].O([H])C([H])([H])C(C([H])([H])O[H])(C([H])([H])O[H])N([H])[H]
Formula:	C₂₄H₄₅NO₈
M.Wt:	475.62
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:	Dinoprost(Prostaglandin F2α) tromethamine salt is a naturally occurring prostaglandin used in medicine to induce labor and as an abortifacient.
References:	[1]. Sharma I, et al. Role of 8-iso-prostaglandin F2alpha and 25-hydroxycholesterol in the pathophysiology of endometriosis. Fertil Steril. 2010 Jun;94(1):63-70. [2]. Coulthard G, et al. Stereocontrolled organocatalytic synthesis of prostaglandin PGF2α in seven steps. Nature. 2012 Sep 13;489(7415):278-81.

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC79609	NCGC00685960	NCGC00685960 is a Nicotinamide N-methyltransferase (NNMT) inhibitor with an IC50 < 10  nM. NCGC00685960 has potent antitumor activity. NCGC00685960 increases H3K27 trimethylation levels in ovarian cancer cells and inhibits α-SMA expression in NNMT-expressing ovarian fibroblasts. NCGC00685960 reduces 1-MNA levels, reverses SAM and H3K27 hypomethylation and significantly impairs collagen contractility in cancer-associated fibroblasts (CAFs). NCGC00685960 can be used for cancers research.
DC77831	Vicadrostat	Vicadrostat (compound 29 A) is a potent and selective inhibitor of aldosterone synthase(CYP11B2) with an IC50 of 16 nM. It exhibits potential in renal disease, diabetic nephropathy, cardiovascular diseases and fibrotic disorder research.
DC77813	Zeltociclib	Zeltociclib is a cyclin-dependent kinase inhibitor with antitumor effects.
DC77714	S3226	S3226 is an inhibitor for Na+/H+ exchange subtype 3 (NHE3) with an IC50 of 0.2 µmol/L in rat NHE3 transfected fibroblasts. S3226 exhibits protective activity in rat ischemia-induced acute renal failure models.
DC77387	AUR1545	AUR1545 is a selective degrader of KAT2A and KAT2B. AUR1545 can be used in the cancer research, including studies on AML (Acute myeloid leukemia), SCLC (Small-cell carcinoma), and NEPC (Neuroendocrine Prostate Cancer).
DC77822	JNJ-77242113 (Icotrokinr)	Icotrokinra (JNJ-77242113, JNJ-2113, PN-235) is an orally available and selective antagonist of the IL-23 receptor. It also inhibits IL-23–induced STAT3 phosphorylation in peripheral blood mononuclear cells with an IC50 of 5.6 pM and suppresses IL-23–induced IFN-γ production in NK cells with an IC50 of 18.4 pM. It also exhibits anti-inflammatory activity in a TNBS-induced colitis model in rats and holds potential for studying psoriasis, psoriatic arthritis, and inflammatory bowel disease.
DC77088	T025	T025 is as an orally available and potent inhibitor of Cdc2‐like kinases (CLKs) with an IC50s of 0.93 nM, 1 nM, 14 nM, 1.5 nM for CLK1, CLK2, CLK3, DYRK1B respectively. It exhibits anti‐tumor efficacy and can be used in MYC‐driven cancer research.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.